The Clorox Company (NYSE:CLX) Stock Holdings Lifted by Coston McIsaac & Partners

Coston McIsaac & Partners boosted its position in shares of The Clorox Company (NYSE:CLX) by 3.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 34,479 shares of the company’s stock after purchasing an additional 1,048 shares during the period. Clorox accounts for 1.6% of Coston McIsaac & Partners’ investment portfolio, making the stock its 22nd biggest holding. Coston McIsaac & Partners’ holdings in Clorox were worth $5,616,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of CLX. Innealta Capital LLC acquired a new position in shares of Clorox during the second quarter valued at about $30,000. Trifecta Capital Advisors LLC grew its stake in Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the last quarter. GoalVest Advisory LLC bought a new stake in shares of Clorox during the first quarter valued at approximately $31,000. First Foundation Advisors bought a new stake in shares of Clorox during the first quarter valued at approximately $31,000. Finally, Family Firm Inc. bought a new stake in shares of Clorox during the second quarter valued at approximately $31,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CLX has been the topic of several analyst reports. Citigroup increased their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Evercore ISI cut their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Finally, Barclays increased their target price on shares of Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a report on Friday, October 11th. Six research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, Clorox has an average rating of “Hold” and a consensus target price of $150.14.

Clorox Price Performance

Shares of Clorox stock traded down $0.02 during midday trading on Wednesday, hitting $157.93. 237,219 shares of the company traded hands, compared to its average volume of 1,221,771. The stock has a market cap of $19.61 billion, a price-to-earnings ratio of 82.50, a PEG ratio of 3.19 and a beta of 0.41. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The firm’s fifty day moving average price is $159.96 and its 200-day moving average price is $145.33. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.09.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. As a group, sell-side analysts forecast that The Clorox Company will post 6.64 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.09%. Clorox’s dividend payout ratio (DPR) is 252.85%.

Insider Transactions at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.51% of the stock is owned by corporate insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.